Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Indian J Pediatr ; 2001 Jan; 68(1): 11-4
Article in English | IMSEAR | ID: sea-83397

ABSTRACT

Fifty-six patients with postpneumonic empyema were treated by sulbactam/ampicillin or cephalothin and netilmicin. Dose of sulbactam/ampicillin was 200 mg/kg per day and of cephalothin was 200 mg/kg per day, and of netilmicin was 5 mg/kg per day. Sulbactam/ampicillin alone was used in 27 patients. Twenty-nine patients were treated with cephalothin plus netilmicin. Days on intravenous antibiotics, days with chest tube, decortication rate, and duration of hospitalization were significantly shorter in sulbactam/ampicillin treatment group compared to cephalothin plus netilmicin group. This study shows that sulbactam/ampicillin is a safe and effective agent in the treatment of postpneumonic empyema in childhood.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Chi-Square Distribution , Child , Child, Preschool , Drug Therapy, Combination , Empyema, Pleural/drug therapy , Female , Gentamicins/therapeutic use , Humans , Infant , Lactams , Male , Netilmicin/therapeutic use , Pneumonia, Bacterial/complications , Statistics, Nonparametric
SELECTION OF CITATIONS
SEARCH DETAIL